• Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

ABCZY:US

6.1000 USD 0.1000 1.67%

As of 20:10:04 ET on 11/20/2014.

Snapshot for Abcam PLC (ABCZY)

Open: 6.1000 Day's Range: 6.1000 - 6.1000 Volume: 1,361
Previous Close: 6.0000 52wk Range: 5.6500 - 8.7400 1-Yr Rtn: -19.23%

Stock Chart for ABCZY

No chart data available.
  • ABCZY:US 6.1000
  • 1D
  • 1M
  • 1Y
6.0000
Interactive ABCZY Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ABCZY

Current P/E Ratio (ttm) -
Estimated P/E(06/2015) 20.7826
Relative P/E vs. SPX -
Earnings Per Share (GBP) (ttm) -
Est. EPS (GBP) (06/2015) 0.1870
Est. PEG Ratio 1.6626
Market Cap (M USD) 1,222.72
Shares Outstanding (M) 200.45
30 Day Average Volume 658
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 2.78%
Cash Dividend (USD) 0.0726
Dividend Ex-Date 11/05/2014
5 Year Dividend Growth -
Next Earnings Announcement 03/03/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ABCZY

  • Revenue
  • Net Income (M/GBP)
  • Profit Margin (%)

Company Profile & Key Executives for ABCZY

Abcam PLC produces and distributes research-grade antibodies via an online catalog. The Company's customers include universities, research institutes, and pharmaceutical and biotechnology companies in countries around the world.

Jonathan Simon MilnerDeputy Chairman/Co-FounderAlan HirzelChief Executive Officer
Jeff IliffeCFO/SecretarySean HickeyChief Investment Officer
More Company Profile & Key Executives for ABCZY

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil